The N-6 methyladenosine dynamics in STEMI and the effect of IL-6 inhibition – a hypothesis generating sub-study of the ASSAIL-MI trial
BackgroundEpitranscriptomics, with m6A as the most prevalent in mammals, is a novel treatment target for inflammatory diseases, including cardiovascular diseases. However, little is known about m6A RNA-regulation during myocardial infarction (MI).Metho…